(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Erytech Pharma S.A., GX Acquisition Corp., and GX Acquisition Corp..

Rank Financial Asset Price Change Updated (EST)
1 Erytech Pharma S.A. (ERYP) 6.37 54.99% 2021-08-01 19:48:25
2 GX Acquisition Corp. (GXGXW) 1.70 41.67% 2021-08-02 01:05:12
3 GX Acquisition Corp. (GXGXU) 11.63 36.5% 2021-08-02 00:54:41
4 Grid Dynamics Holdings (GDYNW) 9.47 21.88% 2021-08-01 23:31:26
5 PAVmed (PAVMW) 2.96 12.55% 2021-08-02 12:46:08
6 Canaan (CAN) 7.74 12.5% 2021-08-02 15:12:23
7 ON Semiconductor (ON) 43.64 11.73% 2021-08-02 15:36:19
8 ECMOHO Limited (MOHO) 1.44 11.63% 2021-08-02 08:24:09
9 Arcturus Therapeutics (ARCT) 34.66 10.7% 2021-08-02 15:12:04
10 Grid Dynamics Holdings (GDYN) 21.05 10.44% 2021-08-01 23:26:24

The three most active and biggest losers today are Onconova Therapeutics, Hycroft Mining Holding Corporation, and Eyegate Pharmaceuticals.

Rank Financial Asset Price Change Updated (EST)
1 Onconova Therapeutics (ONTXW) 0.07 -25.44% 2021-08-02 11:42:09
2 Hycroft Mining Holding Corporation (HYMCW) 0.43 -17.27% 2021-08-02 02:14:05
3 Eyegate Pharmaceuticals (EYEG) 2.52 -13.1% 2021-08-01 20:42:06
4 Mediaco Holding (MDIA) 5.91 -13.09% 2021-08-02 07:42:05
5 NeuroMetrix (NURO) 13.12 -11.95% 2021-08-02 15:35:26
6 Q&K International Group Limited (QK) 1.13 -11.72% 2021-08-02 15:26:36
7 Global Payments (GPN) 171.79 -11.18% 2021-08-02 15:39:35
8 IMAC Holdings (IMACW) 0.37 -10.82% 2021-08-02 03:17:23
9 Iterum Therapeutics plc (ITRM) 0.78 -10.34% 2021-08-02 04:12:08
10 ENDRA Life Sciences (NDRAW) 0.49 -9.24% 2021-08-02 09:44:09

Most Active Winners today

1. Erytech Pharma S.A. (ERYP) – 54.99%

NASDAQ Composite ended the session with Erytech Pharma S.A. rising 54.99% to $6.37 on Monday, following the last session’s upward trend. NASDAQ Composite rose 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Erytech Pharma S.A. is 58776100 which is 5978.96% above its average volume of 966879.

Erytech Pharma S.A.’s last close was $6.37, 54.34% under its 52-week high of $13.95.

Erytech Pharma S.A.’s Revenue

Year-on-year quarterly revenue growth grew by 92.8%, now sitting on 4.41M for the twelve trailing months.

Erytech Pharma S.A.’s Stock Yearly Top and Bottom Value

Erytech Pharma S.A.’s stock is valued at $6.37 at 17:32 EST, way under its 52-week high of $13.95 and way higher than its 52-week low of $4.10.

Erytech Pharma S.A.’s Moving Average

Erytech Pharma S.A.’s worth is way above its 50-day moving average of $4.78 and way below its 200-day moving average of $7.13.

More news about Erytech Pharma S.A..

2. GX Acquisition Corp. (GXGXW) – 41.67%

NASDAQ Composite ended the session with GX Acquisition Corp. rising 41.67% to $1.70 on Monday while NASDAQ Composite jumped 0.06% to $14,681.07.

GX Acquisition Corp.’s last close was $1.70, 29.17% under its 52-week high of $2.40.

GX Acquisition Corp.’s Stock Yearly Top and Bottom Value

GX Acquisition Corp.’s stock is valued at $1.70 at 17:32 EST, way under its 52-week high of $2.40 and way higher than its 52-week low of $1.17.

More news about GX Acquisition Corp..

3. GX Acquisition Corp. (GXGXU) – 36.5%

NASDAQ Composite ended the session with GX Acquisition Corp. rising 36.5% to $11.63 on Monday while NASDAQ Composite jumped 0.06% to $14,681.07.

Volume

Today’s last reported volume for GX Acquisition Corp. is 16188 which is 4019.08% above its average volume of 393.

GX Acquisition Corp.’s last close was $11.63, 16.93% below its 52-week high of $14.00.

GX Acquisition Corp.’s Stock Yearly Top and Bottom Value

GX Acquisition Corp.’s stock is valued at $11.63 at 17:32 EST, way under its 52-week high of $14.00 and way higher than its 52-week low of $8.52.

GX Acquisition Corp.’s Moving Average

GX Acquisition Corp.’s value is above its 50-day moving average of $10.80 and higher than its 200-day moving average of $10.84.

More news about GX Acquisition Corp..

4. Grid Dynamics Holdings (GDYNW) – 21.88%

NASDAQ Composite ended the session with Grid Dynamics Holdings jumping 21.88% to $9.47 on Monday while NASDAQ Composite rose 0.06% to $14,681.07.

Grid Dynamics Holdings’s last close was $9.47, 10.83% under its 52-week high of $10.62.

Grid Dynamics Holdings’s Stock Yearly Top and Bottom Value

Grid Dynamics Holdings’s stock is valued at $9.47 at 17:32 EST, way below its 52-week high of $10.62 and higher than its 52-week low of $8.77.

More news about Grid Dynamics Holdings.

5. PAVmed (PAVMW) – 12.55%

NASDAQ Composite ended the session with PAVmed jumping 12.55% to $2.96 on Monday, following the last session’s downward trend. NASDAQ Composite jumped 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for PAVmed is 1249 which is 73.28% below its average volume of 4674.

PAVmed’s last close was $2.63, 62.1% under its 52-week high of $6.94.

PAVmed’s Stock Yearly Top and Bottom Value

PAVmed’s stock is valued at $2.96 at 17:32 EST, way under its 52-week high of $6.94 and way above its 52-week low of $0.07.

PAVmed’s Moving Average

PAVmed’s value is way above its 50-day moving average of $1.97 and way above its 200-day moving average of $1.47.

More news about PAVmed.

6. Canaan (CAN) – 12.5%

NASDAQ Composite ended the session with Canaan jumping 12.5% to $7.74 on Monday, following the last session’s upward trend. NASDAQ Composite rose 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Canaan is 11337800 which is 50.36% above its average volume of 7540580.

Canaan’s last close was $6.88, 82.4% under its 52-week high of $39.10.

Canaan’s Revenue

Year-on-year quarterly revenue growth grew by 489.9%, now sitting on 782.19M for the twelve trailing months.

Canaan’s Stock Yearly Top and Bottom Value

Canaan’s stock is valued at $7.74 at 17:32 EST, way below its 52-week high of $39.10 and way higher than its 52-week low of $1.80.

Canaan’s Moving Average

Canaan’s worth is higher than its 50-day moving average of $7.36 and way under its 200-day moving average of $12.46.

More news about Canaan.

7. ON Semiconductor (ON) – 11.73%

NASDAQ Composite ended the session with ON Semiconductor jumping 11.73% to $43.64 on Monday, after three sequential sessions in a row of gains. NASDAQ Composite jumped 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for ON Semiconductor is 17289500 which is 210.88% above its average volume of 5561500.

ON Semiconductor’s last close was $39.06, 13.55% below its 52-week high of $45.18.

News about ON Semiconductor today

ON semiconductor corp. Q2 adjusted earnings beat estimates. According to today’s article on Business Insider, " -Excluding items, ON Semiconductor Corp. reported adjusted earnings of $275.8 million or $0.63 per share for the period. "

ON semiconductor stock surges after record earnings that beat expectations, upbeat outlook. According to today’s article on MarketWatch, "Shares of ON Semiconductor Corp. shot up 8.2% in premarket trading Monday, after the chipmaker reported record adjusted profit and revenue that beat expectations and provided an upbeat outlook, citing accelerating demand in the automotive and industrial end markets. "

ON Semiconductor’s Sales

ON Semiconductor’s sales growth is 33.8% for the ongoing quarter and 22.3% for the next. The company’s growth estimates for the current quarter and the next is 308.3% and 88.9%, respectively.

ON Semiconductor’s Revenue

Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 5.46B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ON Semiconductor’s stock is considered to be oversold (<=20).

ON Semiconductor’s Stock Yearly Top and Bottom Value

ON Semiconductor’s stock is valued at $43.64 at 17:32 EST, below its 52-week high of $45.18 and way higher than its 52-week low of $19.75.

ON Semiconductor’s Moving Average

ON Semiconductor’s worth is way above its 50-day moving average of $37.21 and way above its 200-day moving average of $38.76.

More news about ON Semiconductor.

8. ECMOHO Limited (MOHO) – 11.63%

NASDAQ Composite ended the session with ECMOHO Limited rising 11.63% to $1.44 on Monday while NASDAQ Composite jumped 0.06% to $14,681.07.

Volume

Today’s last reported volume for ECMOHO Limited is 1273580 which is 697.71% above its average volume of 159655.

ECMOHO Limited’s last close was $1.44, 63.82% under its 52-week high of $3.98.

ECMOHO Limited’s Revenue

Year-on-year quarterly revenue growth declined by 30.4%, now sitting on 304.94M for the twelve trailing months.

ECMOHO Limited’s Stock Yearly Top and Bottom Value

ECMOHO Limited’s stock is valued at $1.44 at 17:32 EST, way below its 52-week high of $3.98 and way above its 52-week low of $1.06.

ECMOHO Limited’s Moving Average

ECMOHO Limited’s value is higher than its 50-day moving average of $1.43 and way below its 200-day moving average of $1.95.

More news about ECMOHO Limited.

9. Arcturus Therapeutics (ARCT) – 10.7%

NASDAQ Composite ended the session with Arcturus Therapeutics rising 10.7% to $34.66 on Monday, following the last session’s upward trend. NASDAQ Composite jumped 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Arcturus Therapeutics is 935573 which is 87.88% above its average volume of 497960.

Arcturus Therapeutics’s last close was $31.31, 75.86% under its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is a negative 34.5% for the ongoing quarter and 321.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 289.1% and a negative 129.3%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $34.66 at 17:32 EST, way under its 52-week high of $129.71 and way above its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is above its 50-day moving average of $32.51 and way below its 200-day moving average of $43.58.

More news about Arcturus Therapeutics.

10. Grid Dynamics Holdings (GDYN) – 10.44%

NASDAQ Composite ended the session with Grid Dynamics Holdings jumping 10.44% to $21.05 on Monday while NASDAQ Composite jumped 0.06% to $14,681.07.

Volume

Today’s last reported volume for Grid Dynamics Holdings is 789493 which is 100.54% above its average volume of 393693.

Grid Dynamics Holdings’s last close was $21.05, 5.39% below its 52-week high of $22.25.

Grid Dynamics Holdings’s Sales

Grid Dynamics Holdings’s sales growth is 85.5% for the ongoing quarter and 61.3% for the next. The company’s growth estimates for the present quarter and the next is 500% and 20%, respectively.

Grid Dynamics Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 117.96M for the twelve trailing months.

Grid Dynamics Holdings’s Stock Yearly Top and Bottom Value

Grid Dynamics Holdings’s stock is valued at $21.05 at 17:32 EST, below its 52-week high of $22.25 and way above its 52-week low of $6.59.

Grid Dynamics Holdings’s Moving Average

Grid Dynamics Holdings’s value is way higher than its 50-day moving average of $18.82 and way higher than its 200-day moving average of $15.86.

More news about Grid Dynamics Holdings.

Most Active Losers Today

1. Onconova Therapeutics (ONTXW) – -25.44%

NASDAQ Composite ended the session with Onconova Therapeutics dropping 25.44% to $0.07 on Monday, after five consecutive sessions in a row of losses. NASDAQ Composite jumped 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat up trend trading session today.

Onconova Therapeutics’s last close was $0.07, 26.34% below its 52-week high of $0.09.

Onconova Therapeutics’s Stock Yearly Top and Bottom Value

Onconova Therapeutics’s stock is valued at $0.07 at 17:32 EST, way under its 52-week high of $0.09 and way higher than its 52-week low of $0.06.

More news about Onconova Therapeutics.

2. Hycroft Mining Holding Corporation (HYMCW) – -17.27%

NASDAQ Composite ended the session with Hycroft Mining Holding Corporation falling 17.27% to $0.43 on Monday, after five successive sessions in a row of losses. NASDAQ Composite rose 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat up trend trading session today.

Hycroft Mining Holding Corporation’s last close was $0.43, 6.6% under its 52-week high of $0.46.

Hycroft Mining Holding Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 70.8%, now sitting on 54.93M for the twelve trailing months.

Hycroft Mining Holding Corporation’s Stock Yearly Top and Bottom Value

Hycroft Mining Holding Corporation’s stock is valued at $0.43 at 17:32 EST, under its 52-week high of $0.46 and above its 52-week low of $0.40.

More news about Hycroft Mining Holding Corporation.

3. Eyegate Pharmaceuticals (EYEG) – -13.1%

NASDAQ Composite ended the session with Eyegate Pharmaceuticals dropping 13.1% to $2.52 on Monday while NASDAQ Composite jumped 0.06% to $14,681.07.

Volume

Today’s last reported volume for Eyegate Pharmaceuticals is 2406560 which is 117.82% above its average volume of 1104860.

Eyegate Pharmaceuticals’s last close was $2.52, 69.19% under its 52-week high of $8.18.

The company’s growth estimates for the current quarter is a negative 10.5% and positive 4.5% for the next.

Eyegate Pharmaceuticals’s Stock Yearly Top and Bottom Value

Eyegate Pharmaceuticals’s stock is valued at $2.52 at 17:32 EST, way under its 52-week high of $8.18 and above its 52-week low of $2.48.

Eyegate Pharmaceuticals’s Moving Average

Eyegate Pharmaceuticals’s worth is way below its 50-day moving average of $3.77 and way below its 200-day moving average of $4.89.

More news about Eyegate Pharmaceuticals.

4. Mediaco Holding (MDIA) – -13.09%

NASDAQ Composite ended the session with Mediaco Holding sliding 13.09% to $5.91 on Monday while NASDAQ Composite rose 0.06% to $14,681.07.

Volume

Today’s last reported volume for Mediaco Holding is 360186 which is 85.25% below its average volume of 2441290.

Mediaco Holding’s last close was $5.91, 66.03% below its 52-week high of $17.40.

Mediaco Holding’s Revenue

Year-on-year quarterly revenue growth declined by 17.3%, now sitting on 37.22M for the twelve trailing months.

Mediaco Holding’s Stock Yearly Top and Bottom Value

Mediaco Holding’s stock is valued at $5.91 at 17:32 EST, way under its 52-week high of $17.40 and way higher than its 52-week low of $2.27.

Mediaco Holding’s Moving Average

Mediaco Holding’s worth is above its 50-day moving average of $5.43 and way above its 200-day moving average of $3.89.

More news about Mediaco Holding.

5. NeuroMetrix (NURO) – -11.95%

NASDAQ Composite ended the session with NeuroMetrix falling 11.95% to $13.12 on Monday, after two sequential sessions in a row of losses. NASDAQ Composite rose 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for NeuroMetrix is 1498740 which is 80.84% below its average volume of 7821390.

NeuroMetrix’s last close was $14.90, 61.55% under its 52-week high of $38.75.

NeuroMetrix’s Revenue

Year-on-year quarterly revenue growth declined by 0.8%, now sitting on 7.36M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NeuroMetrix’s stock is considered to be overbought (>=80).

NeuroMetrix’s Stock Yearly Top and Bottom Value

NeuroMetrix’s stock is valued at $13.12 at 17:32 EST, way below its 52-week high of $38.75 and way higher than its 52-week low of $1.39.

NeuroMetrix’s Moving Average

NeuroMetrix’s worth is way higher than its 50-day moving average of $7.28 and way higher than its 200-day moving average of $4.43.

More news about NeuroMetrix.

6. Q&K International Group Limited (QK) – -11.72%

NASDAQ Composite ended the session with Q&K International Group Limited sliding 11.72% to $1.13 on Monday, after two sequential sessions in a row of gains. NASDAQ Composite jumped 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Q&K International Group Limited is 275405 which is 62.13% below its average volume of 727185.

Q&K International Group Limited’s last close was $1.28, 88.18% below its 52-week high of $10.83.

Q&K International Group Limited’s Revenue

Year-on-year quarterly revenue growth declined by 13.5%, now sitting on 1.21B for the twelve trailing months.

Q&K International Group Limited’s Stock Yearly Top and Bottom Value

Q&K International Group Limited’s stock is valued at $1.13 at 17:32 EST, way under its 52-week high of $10.83 and way higher than its 52-week low of $0.97.

Q&K International Group Limited’s Moving Average

Q&K International Group Limited’s value is way below its 50-day moving average of $1.29 and way below its 200-day moving average of $2.12.

More news about Q&K International Group Limited.

7. Global Payments (GPN) – -11.18%

NYSE Composite ended the session with Global Payments falling 11.18% to $171.79 on Monday, after two successive sessions in a row of gains. NYSE Composite fell 0.16% to $16,576.21, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Global Payments is 8221620 which is 408.21% above its average volume of 1617760.

Global Payments’s last close was $193.41, 12.41% below its 52-week high of $220.81.

News about Global Payments today

Global payments inc. Q2 adjusted earnings beat estimates. According to today’s article on Business Insider, "Excluding items, Global Payments Inc. reported adjusted earnings of $603.00 million or $2.04 per share for the period."

Earnings results: global payments tops earnings expectations. According to today’s article on MarketWatch, "On an adjusted basis, Global Payments earned $2.04 a share, up from $1.31 a share a year prior and ahead of the FactSet consensus, which called for $1.90 a share. "

Global Payments’s Sales

Global Payments’s sales growth is 21.9% for the current quarter and 12.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 44.3% and 24.6%, respectively.

Global Payments’s Revenue

Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 7.51B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Global Payments’s stock is considered to be oversold (<=20).

Global Payments’s Stock Yearly Top and Bottom Value

Global Payments’s stock is valued at $171.79 at 17:32 EST, way below its 52-week high of $220.81 and way above its 52-week low of $153.33.

Global Payments’s Moving Average

Global Payments’s worth is way below its 50-day moving average of $191.60 and way under its 200-day moving average of $198.67.

More news about Global Payments.

8. IMAC Holdings (IMACW) – -10.82%

NASDAQ Composite ended the session with IMAC Holdings sliding 10.82% to $0.37 on Monday, after five sequential sessions in a row of losses. NASDAQ Composite rose 0.06% to $14,681.07, following the last session’s downward trend on what was a somewhat up trend trading session today.

IMAC Holdings’s last close was $0.37, 0% below its 52-week high of $0.37.

IMAC Holdings’s Stock Yearly Top and Bottom Value

IMAC Holdings’s stock is valued at $0.37 at 17:32 EST, below its 52-week low of $0.37.

More news about IMAC Holdings.

9. Iterum Therapeutics plc (ITRM) – -10.34%

NASDAQ Composite ended the session with Iterum Therapeutics plc dropping 10.34% to $0.78 on Monday while NASDAQ Composite rose 0.06% to $14,681.07.

Volume

Today’s last reported volume for Iterum Therapeutics plc is 10572000 which is 27.38% below its average volume of 14557600.

Iterum Therapeutics plc’s last close was $0.78, 73.99% below its 52-week high of $3.00.

The company’s growth estimates for the present quarter and the next is 92.5% and 90%, respectively.

Iterum Therapeutics plc’s Stock Yearly Top and Bottom Value

Iterum Therapeutics plc’s stock is valued at $0.78 at 17:32 EST, way under its 52-week high of $3.00 and way above its 52-week low of $0.45.

Iterum Therapeutics plc’s Moving Average

Iterum Therapeutics plc’s worth is way below its 50-day moving average of $1.51 and way under its 200-day moving average of $1.48.

More news about Iterum Therapeutics plc.

10. ENDRA Life Sciences (NDRAW) – -9.24%

NASDAQ Composite ended the session with ENDRA Life Sciences sliding 9.24% to $0.49 on Monday while NASDAQ Composite jumped 0.06% to $14,681.07.

ENDRA Life Sciences’s last close was $0.47, 4.1% under its 52-week high of $0.49.

ENDRA Life Sciences’s Stock Yearly Top and Bottom Value

ENDRA Life Sciences’s stock is valued at $0.49 at 17:32 EST, under its 52-week low of $0.49.

More news about ENDRA Life Sciences.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here